Priaxon Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Employees
  • 4
Employees
  • Latest Deal Type
  • Grant
  • Investors
  • 3

Priaxon General Information

Description

Developer of molecule therapeutics designed to cure target-ligand interactions. The company's therapeutics offers chemo-informatics tools for identification of molecular determinants of target-ligand interactions, enabling patients to get cure without any side-effects.

Contact Information

Website
www.priaxon.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Siegfriedstr. 8
  • 80803 Munich
  • Germany
+49 089 00000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Priaxon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 08-Jul-2013 Completed Startup
3. Grant 04-Feb-2009 Completed Startup
2. Grant 06-Oct-2008 Completed Startup
1. Early Stage VC 29-May-2008 Completed Startup
To view Priaxon’s complete valuation and funding history, request access »

Priaxon Executive Team (7)

Name Title Board Seat Contact Info
Jürgen Kolb MD Chief Executive Officer
Christoph Burdack Ph.D Chief Scientific Officer
Michael Umkehrer Director Medicinal Chemistry
Gunther Ross Ph.D Director, Research & Development
You’re viewing 4 of 7 executive team members. Get the full list »

Priaxon Board Members (7)

Name Representing Role Since
Aki Prihti Priaxon Board Member 000 0000
Markku Jalkanen Ph.D Inveni Capital Board Member 000 0000
Nicholas Bacopoulos Ph.D Priaxon Board Member 000 0000
Oliver Herd Priaxon Chairman 000 0000
Wolfgang Pieken Ph.D Inveni Capital Chairman of the Supervisory Board 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Priaxon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Priaxon Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bavarian Research Foundation Limited Partner 000 0000 000000 0
Zentrales Innovationsprogramm Mittelstand Other 000 0000 000000 0
Inveni Capital Venture Capital Minority 000 0000 000000 0
To view Priaxon’s complete investors history, request access »